The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Three changes in total to the genetic code were needed to ensure the transplanted donor cells didn't trigger an immune ...

Doctors said insulin-dependent patients with Type 1 diabetes and kidney failure face a severely reduced life span ...

A new study uncovers a pancreas–hippocampus feedback loop that may help explain mood swings in bipolar disorder.

Currently, stem cells and transplants are reserved for people whose diabetes cannot be controlled by the standard treatments.

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes ...

A recent systematic review and meta-analysis conducted by researchers from the Research Institute of the McGill University ...

There have long been two commonly recognized types of diabetes, but a third form may have been discovered, according to a ...

Insulin is known to be produced by pancreatic cells to regulate glucose levels in the blood. It is also a growth factor. Destruction of insulin-producing cells in the pancreas causes Type 1 diabetes, ...

Overall, patients using the bionic pancreas saw a decline in their A1c, a measure of average blood sugar levels over the past three months. It dipped from an average of 7.9% to 7.3%, while the ...

The first drug that can slow the onset of type 1 diabetes has been given the green light for use in the UK. Teplizumab has ...

Sometimes called an ‘artificial pancreas,’ the systems, aided by a glucose sensor, algorithmically determine insulin doses that are delivered continuously through a pump.